Discussing the Safety Profile of an Antiseizure Medication With Patients and Caregivers

Join Jessica Bishop, MPAS, PA-C, as she models a patient discussion about the safety profile of FYCOMPA® (perampanel), with a focus on the Boxed WARNING regarding serious psychiatric and behavioral reactions. She also presents the data behind the Boxed WARNING.

View Transcript
Share

INDICATION
FYCOMPA® (perampanel) is indicated in patients with epilepsy aged 4 years and older for partial-onset seizures (POS) with or without secondarily generalized seizures and adjunctive therapy for patients aged 12 years and older for primary generalized tonic-clonic (PGTC) seizures.

Please see additional Important Safety Information throughout and full US Prescribing Information, including Boxed WARNING.

Faculty

Jessica A. Bishop, MPAS, PA-C
Consultants In Epilepsy & Neurology
Boise, Idaho